BeiGene | Cancer Has No Borders. Neither Do We.

Web Name: BeiGene | Cancer Has No Borders. Neither Do We.

WebSite: http://www.beigene.ca

ID:324752

Keywords:

Has,No,BeiGene,Cancer

Description:


Skip to main content
​​ GlobalUSChina

Find out what BeiGene is doing in your region/marketplace.

AmericanUnited States ENCanada EN | FREuropeanGermany DEAsia-PacificChinaAustralia ENGlobalUSChina

Find out what BeiGene is doing in your region/marketplace.

AmericanUnited States ENCanada EN | FREuropeanGermany DEAsia-PacificChinaAustralia EN

 

InvestorsNASDAQ investorsHKEX investorsSSE InvestorsMediaContact MediaContact InvestorsNASDAQ investorsHKEX investorsMedia InvestorsNASDAQ investorsHKEX investorsSSE InvestorsMediaContact

 

        
 En中文 

This website uses cookies to improve your overall experience. For more information about how BeiGene uses cookies,  please refer to our Privacy Policy.

Close

X

 
BeiGene’s New LogoLearn more about the story behind our new logoProduct in CanadaLearn more about BRUKINSA® (zanubrutinib) in CanadaNews in Canada BRUKINSA® is now available in Canada

We are passionate about applying cutting-edge science to the development of life-changing therapies. Cancer has no borders. Neither do we.

About Us

News

BeiGene News

See all News

September 19, 2022 BeiGene Receives Positive CHMP Opinion for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Marginal Zone Lymphoma

BeiGene Receives Positive CHMP Opinion for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Marginal Zone Lymphoma

Read More September 19, 2022 NICE Recommends BeiGene’s BRUKINSA® (zanubrutinib) for Patients with Waldenström’s Macroglobulinemia who have had at Least One Treatment

NICE Recommends BeiGene’s BRUKINSA® (zanubrutinib) for Patients with Waldenström’s Macroglobulinemia who have had at Least One Treatment

Read More September 10, 2022 BeiGene Announces Data Presentations at ESMO 2022 Including Late-Breaking Oral Presentation for Tislelizumab in First-Line Unresectable Hepatocellular Cancer

BeiGene Announces Data Presentations at ESMO 2022 Including Late-Breaking Oral Presentation for Tislelizumab in First-Line Unresectable Hepatocellular Cancer

Read More September 7, 2022 BeiGene to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

BeiGene to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Read More August 23, 2022 BeiGene Announces Acceptance of 11th Regulatory Submission for PD-1 Inhibitor Tislelizumab in China

BeiGene Announces Acceptance of 11th Regulatory Submission for PD-1 Inhibitor Tislelizumab in China

Read More August 15, 2022 BeiGene Announces Strategic Alliance with Ontada to Improve U.S. Community Oncology Care

BeiGene Announces Strategic Alliance with Ontada to Improve U.S. Community Oncology Care

Read More BeiGene Facts2010FoundedNASDAQ: BGNE  
HKEX: 06160
Listings8Internally Developed
Clinical Candidates
8Marketed
Products
in China1Approved
Product
in the U.S.
8,000+Global Team

Partnering

Partnerships that Extend Around the Globe

BeiGene is the partner of choice in China for development and commercialization. Read more about our current partnerships and opportunities to build business relationships.

Partners

Our Patients

Our Commitment to Patients

At BeiGene we are focused not only on the underserved global cancer patient population, but also on individual people fighting their illnesses.

Patients

Careers

Careers

Join Our
Team

We’re looking for highly motivated colleagues who can collaborate with us as we build a company that will have a lasting impact on the global fight against cancer.

Careers

 

© 2021 BeiGene. All Rights Reserved.

TAGS:Has No BeiGene Cancer

<<< Thank you for your visit >>>

Websites to related :
Turbina hidráulica, central hid

   +86 731 8890 6157 [correo electrónico protegido] EN

Turbina hidráulica, estação h

   +86 731 8890 6157 [email protegido] EN EN

主頁 | DELL Technologies - EMEA

  DELL Technologies - EMEA events Gallery選單 »主頁 語言語言Afrikaans [ZA]Afrikaans Argentina [AR]Argentina Azərbaycanca [AZ]Azərbayca

Shenzhen Evertones Technology Co

  

Best Mobile Bitcoin Casino USA

  Skip to the content

Elu Produit de l'Année - Le con

  twitterfacebooklinkedinGrensstraat 166 - 1970 Wezembeek-Oppem +32 2 678 06 06 info@poybelgium.comPrimary MenuORGANISATIONLa sociétéLe logoLes parten

Hermasa &#8211; Diseño y fabric

  

silicone, rubber, sex toy | Jian

   +86 0750-3622879 Contact Now

kinosvet.tv

  

Inti-renovation |

  AccueilArchitectureRénovationRestructurationRéalisationsBlogContactSélectionner une page Conception et réalisationNous prenons ensemble votre pr

ads

Hot Websites